Innate Pharma, Inc
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$3.3M
Doctors Paid
135
Transactions
299
2021 Total
$172,701
Payment Breakdown by Category
Research$3.3M (97.8%)
Consulting$29,136 (0.9%)
Food & Beverage$3,464 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3.3M | 170 | 97.8% |
| Honoraria | $39,750 | 20 | 1.2% |
| Consulting Fee | $29,136 | 9 | 0.9% |
| Food and Beverage | $3,464 | 100 | 0.1% |
Payments by Type
Research
$3.3M
170 transactions
General
$72,350
129 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Study of IPH2201 (Monalizumab) and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | $2.2M | 0 | 88 |
| An Open Label, Multicohort, Multi-center Phase II Study Evaluating the Efficacy and Safety of IPH4102/Lacutamab Alone or in Combination With Chemotherapy in Patients With Advanced T-cell Lymphoma | $440,121 | 1 | 24 |
| A Phase I Study of Moxetumomab Pasudotox-tdfk (Lumoxiti) and Rituximab (Rituxan) for Relapsed Hairy Cell Leukemia | $212,080 | 0 | 2 |
| A Phase I Study of the Anti-C5aR, Avdoralimab (IPH5401), in Combination With the Anti-PD-L1, Durvalumab, in Patients With Selected Advanced Solid Tumors | $155,954 | 0 | 23 |
| A phase-I study of the anti-C5aR, IPH5401, in combination with the anti-PDL-1, durvalumab, in patients with selected advanced solid tumors | $150,989 | 6 | 20 |
| Open Label, Multicenter Phase I Study of IPH4102, a Humanized Anti-KIR3DL2 Monoclonal Antibody, in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL) | $129,531 | 0 | 13 |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Medical Oncology | $140,001 | 19 | $7,368 |
| Hematology & Oncology | $40,770 | 72 | $566.25 |
| Internal Medicine | $21,440 | 18 | $1,191 |
| Dermatopathology | $14,848 | 1 | $14,848 |
| Hematology | $11,868 | 13 | $912.91 |
| Specialist | $1,268 | 6 | $211.30 |
| Dermatology | $483.33 | 1 | $483.33 |
| Hospice and Palliative Medicine | $36.91 | 2 | $18.46 |
| Gynecologic Oncology | $19.03 | 1 | $19.03 |
| Pediatrics | $12.35 | 1 | $12.35 |
Top Paid Doctors — Page 5
| Doctor | Specialty | Location | Total | 2020 |
|---|---|---|---|---|
| Deepali Sharma, M.d, M.D | Internal Medicine | Riverhead, NY | $14.14 | $0 |
| Mr. Ihsan Haq, M.d, M.D | Specialist | Findlay, OH | $13.98 | $0 |
| Shaker Dakhil, Md, MD | Hematology & Oncology | Wichita, KS | $13.97 | $0 |
| Dr. Christopher Dakhil, M.d, M.D | Internal Medicine | Wichita, KS | $13.97 | $0 |
| Hemang Dave, M.d, M.D | Hematology & Oncology | Marmora, NJ | $13.85 | $0 |
| Judie Goodman, Do, DO | Hematology & Oncology | Pontiac, MI | $13.72 | $0 |
| Daniel Spitz, M.d, M.D | Medical Oncology | West Palm Beach, FL | $13.54 | $0 |
| Avram Smukler, M.d, M.D | Hematology | West Palm Beach, FL | $13.54 | $0 |
| Robert Green, M.d, M.D | Hematology & Oncology | Nashville, TN | $13.54 | $0 |
| Dr. Elizabeth Byron, M.d, M.D | Hematology | Palm Springs, FL | $13.54 | $0 |
| Neal Rothschild, M.d, M.D | Medical Oncology | West Palm Beach, FL | $13.54 | $0 |
| Barry Berman, M.d, M.D | Hematology | West Palm Beach, FL | $13.54 | $0 |
| Hao Zhang, M.d, M.D | Hematology & Oncology | Los Angeles, CA | $13.40 | $0 |
| Mitchell Alden, D.o, D.O | Hematology & Oncology | Sellersville, PA | $13.22 | $0 |
| Dr. Nishan Tchekmedyian, Md, MD | Hematology & Oncology | Huntington Beach, CA | $13.20 | $0 |
| Dr. Martin Tapia, Md, MD | Internal Medicine | Royal Oak, MI | $13.05 | $0 |
| Dr. Kiem Liem, M.d, M.D | Hematology & Oncology | Long Beach, CA | $12.97 | $0 |
| Dr. Lihong Wu, M.d, M.D | Hematology & Oncology | Long Beach, CA | $12.97 | $0 |
| Dr. James Jin, M.d, M.D | Medical Oncology | South Bend, IN | $12.96 | $0 |
| Dr. Ahsanul Haque, M.d, M.D | Hematology & Oncology | Elkhart, IN | $12.96 | $0 |
| Dr. Mitchell Folbe, Md, MD | Hematology & Oncology | Troy, MI | $12.95 | $0 |
| Dr. Courtney Ackerman, M.d, M.D | Hematology & Oncology | Silver Spring, MD | $12.89 | $0 |
| Kelty Baker, Md, MD | Hematology | Houston, TX | $12.80 | $0 |
| Dr. Krisztina Larson, M.d, M.D | Hematology & Oncology | Burbank, CA | $12.56 | $0 |
| Brent Mullins, M.d, M.D | Hematology & Oncology | Memphis, TN | $12.47 | $0 |
About Innate Pharma, Inc
Innate Pharma, Inc has made $3.3M in payments to 135 healthcare providers, recorded across 299 transactions in the CMS Open Payments database. In 2021, the company paid $172,701. The top product by payment volume is Lumoxiti ($435,419).
Payments were distributed across 10 medical specialties. The top specialty by payment amount is Medical Oncology ($140,001 to 19 doctors).
Payment categories include: Food & Beverage ($3,464), Consulting ($29,136), Research ($3.3M).
Innate Pharma, Inc is associated with 1 products in the CMS Open Payments database.